Indacaterol/ glycopyrronium/ mometasone (Enerzair breezhaler)

Status:

Grey - after consultant/specialist initiation

Decision Date:

August 2021

Comments

GREY after specialist initiation: to be used in severe asthma with a demonstrated airflow obstruction

 

Brown Drug Classifications

• 8. Exceptionality where a small cohort of patients may benefit from prescribing can be identified

search again